New criteria for Alzheimer's diagnosis allows for preclinical treatment

10/12/2010 | Yahoo!

International Alzheimer's disease experts are suggesting that patients who have episodic memory impairment along with at least one positive biomarker be diagnosed with the disease. The new criteria for diagnosis would allow more patients to get treatment or qualify for clinical trials. "There is no longer a reason to wait until patients have developed full-blown dementia," said Bruno Dubois, leader of the International Working Group for New Research Criteria for the Diagnosis of Alzheimer's Disease.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC